Top 50 Frequently Used Diagnostic Codes Dermatology

Total Page:16

File Type:pdf, Size:1020Kb

Top 50 Frequently Used Diagnostic Codes Dermatology Top 50 Frequently Used Diagnostic Codes Dermatology ICD-9 Code ICD-9 Description ICD-10 Code and Description 238.2 Unc Behav Neo Skin D48.5 Neoplasm of uncertain behavior of skin 216.5 Benign Neo Skin Trunk D23.5 Other benign neoplasm of skin of trunk V58.69 Encounter Long Rx Use Ot Z79.891 Long term (current) use of opiate analgesic Z79.899 Other long term (current) drug therapy 706.1 Ot Acne L70.0 Acne vulgaris L70.1 Acne conglobata L70.8 Other acne 702.19 Seborrheic Keratosis Ot L82.1 Other seborrheic keratosis 702.11 Inflamed Seborr Keratos L82.0 Inflamed seborrheic keratosis 702.0 Actinic Keratosis L57.0 Actinic keratosis 173.31 Basal Cell Carcin Ot Face C44.310 Basal cell carcinoma of skin of unspecified parts of face C44.311 Basal cell carcinoma of skin of nose C44.319 Basal cell carcinoma of skin of other parts of face 709.2 Scar And Fibrosis Of Skin L90.5 Scar conditions and fibrosis of skin 078.10 Viral Warts Unspecified B07.9 Viral wart, unspecified 216.9 Benign Neo Skin Unspec D23.9 Other benign neoplasm of skin, unspecified 216.6 Benign Neo Skin Arm D23.60 Oth benign neoplasm skin/ unsp upper limb, inc shoulder 706.2 Sebaceous Cyst L72.3 Sebaceous cyst 216.7 Benign Neo Skin Leg D23.70 Oth benign neoplasm skin/ unsp lower limb, including hip 216.3 Benign Neo Skin Face Ot D23.30 Other benign neoplasm of skin of unspecified part of face D23.39 Other benign neoplasm of skin of other parts of face 696.1 Ot Psoriasis L40.0 Psoriasis vulgaris L40.1 Generalized pustular psoriasis L40.2 Acrodermatitis continua L40.3 Pustulosis palmaris et plantaris L40.4 Guttate psoriasis L40.8 Other psoriasis 173.51 Basal Cell Carcin Trunk C44.510 Basal cell carcinoma of anal skin C44.511 Basal cell carcinoma of skin of breast C44.519 Basal cell carcinoma of skin of other part of trunk 692.9 Dermatitis Unspec L25.9 Unspecified contact dermatitis, unspecified cause 173.62 Squam Cell Carcinoma Arm C44.621 Squamous cell carcinoma skin/ unsp upper limb, inc shoulder 173.61 Basal Cell Carcinoma Arm C44.611 Basal cell carcinoma skin/ unsp upper limb, inc shoulder 173.91 Basal Cell Carcin Uns Skin C44.91 Basal cell carcinoma of skin, unspecified ICD-9 Code ICD-9 Description ICD-10 Code and Description 684 Impetigo L01.00 Impetigo, unspecified L01.03 Bullous impetigo 216.4 Benign Neo Scalp/Skin Neck D23.4 Other benign neoplasm of skin of scalp and neck 173.32 Squam Cell Carcin Ot Face C44.320 Squamous cell carcinoma of skin of unspecified parts of face C44.321 Squamous cell carcinoma of skin of nose C44.329 Squamous cell carcinoma of skin of other parts of face 173.41 Basal Cell Carcin Scalp C44.41 Basal cell carcinoma of skin of scalp and neck 709.9 Unsp Skin Disorder L98.9 Disorder of the skin and subcutaneous tissue, unspecified 228.01 Hemangioma Skin D18.01 Hemangioma of skin and subcutaneous tissue 682.9 Unsp Cellulitis/Abscess L03.90 Cellulitis, unspecified L03.91 Acute lymphangitis, unspecified 173.92 Squam Cell Carcin Uns Skin C44.92 Squamous cell carcinoma of skin, unspecified 232.6 Ca In Situ Skin Arm D04.60 Ca in situ skin of unsp upper limb, including shoulder 173.72 Squam Cell Carcinoma Leg C44.721 Squamous cell carcinoma skin/ unsp lower limb, including hip 110.1 Dermatophytosis Of Nail B35.1 Tinea unguium 782.1 Nonspecif Skin Erupt Ot R21 Rash and other nonspecific skin eruption 173.71 Basal Cell Carcinoma Leg C44.711 Basal cell carcinoma skin/ unsp lower limb, including hip 704.00 Alopecia Unsp L65.9 Nonscarring hair loss, unspecified 686.9 Local Skin Infection Unspec L08.9 Local infection of the skin and subcutaneous tissue, unsp 173.21 Basal Cell Carcinoma Ear C44.211 Basal cell carcinoma skin/ unsp ear and external auric canal 698.3 Lichenification L28.0 Lichen simplex chronicus L28.1 Prurigo nodularis 232.3 Ca In Situ Skin Face Ot D04.30 Carcinoma in situ of skin of unspecified part of face D04.39 Carcinoma in situ of skin of other parts of face 704.8 Ot Hair Disease L66.3 Perifolliculitis capitis abscedens L73.8 Other specified follicular disorders 701.9 Skin Hypertro/Atroph Unspec L90.9 Atrophic disorder of skin, unspecified L91.9 Hypertrophic disorder of the skin, unspecified 173.42 Squam Cell Carcin Scalp C44.42 Squamous cell carcinoma of skin of scalp and neck 173.52 Squam Cell Carcin Trunk C44.520 Squamous cell carcinoma of anal skin C44.521 Squamous cell carcinoma of skin of breast C44.529 Squamous cell carcinoma of skin of other part of trunk 704.42 Trichilemmal Cyst L72.12 Trichodermal cyst 173.22 Squam Cell Carcinoma Ear C44.221 Squamous cell carcinoma skin/ unsp ear and extrn auric canal 703.8 Ot Diseases Of Nail L60.1 Onycholysis L60.2 Onychogryphosis L60.3 Nail dystrophy L60.4 Beau's lines L60.8 Other nail disorders 704.9 Unsp Hair Disease L73.9 Follicular disorder, unspecified 698.4 Dermatitis Factitia L98.1 Factitial dermatitis 709.09 Ot Dyschromia L81.8 Other specified disorders of pigmentation 232.9 Ca In Situ Skin Unspec D04.9 Carcinoma in situ of skin, unspecified The above list is provided for informational purposes only and is not exhaustive or exclusive. CPT codes included are based on PathGroup’s most frequently utilized diagnosis codes per designated medical specialty in 2014. Crosswalk information was compiled from the ICD-10-CM 2015 issued by the Centers for Medicaid and Medicare Services. This list is intended to aid physicians when providing ICD-10 Diagnosis Codes as required by Medicare and other Insurers. Correct coding is the responsibility of the ordering physician. For a full reference, an ICD-10-CM book is recommended. .
Recommended publications
  • Rapid Development of Perifolliculitis Following Mesotherapy
    CASE LETTER Rapid Development of Perifolliculitis Following Mesotherapy Weihuang Vivian Ning, MD; Sameer Bashey, MD; Gene H. Kim, MD patient received mesotherapy with an unknown substance PRACTICE POINTS for cosmetic rejuvenation; the rash was localized only to the injection sites.copy She did not note any fever, chills, • Mesotherapy—the delivery of vitamins, chemicals, and plant extracts directly into the dermis via nausea, vomiting, diarrhea, headache, arthralgia, or upper injections—is a common procedure performed respiratory tract symptoms. She further denied starting in both medical and nonmedical settings for any new medications, herbal products, or topical therapies cosmetic rejuvenation. apart from the procedure she had received 2 weeks prior. • Complications can occur from mesotherapy treatment. Thenot patient was found to be in no acute distress and • Patients should be advised to seek medical care with vital signs were stable. Laboratory testing was remarkable US Food and Drug Administration–approved cosmetic for elevations in alanine aminotransferase (62 U/L [refer- techniques and substances only. ence range, 10–40 U/L]) and aspartate aminotransferase (72 U/L [reference range 10–30 U/L]). Moreover, she had Doan absolute neutrophil count of 0.5×103 cells/µL (refer- ence range 1.8–8.0×103 cells/µL). An electrolyte panel, To the Editor: creatinine level, and urinalysis were normal. Physical Mesotherapy, also known as intradermotherapy, is a examination revealed numerous 4- to 5-mm erythematous cosmetic procedure in which multiple
    [Show full text]
  • Dermatologists' Perceptions on the Utility and Limitations
    RESEARCH/Original Article Journal of Telemedicine and Telecare 2021, Vol. 27(3) 166–173 Dermatologists’ perceptions on the ! The Author(s) 2019 utility and limitations of teledermatology Article reuse guidelines: sagepub.com/journals-permissions after examining 55,000 lesions DOI: 10.1177/1357633X19864829 journals.sagepub.com/home/jtt Mara Giavina Bianchi , Andre Santos and Eduardo Cordioli Abstract Introduction: Few studies have assessed the perception of teledermatologists about the utility and limitations of teledermatology, especially to diagnose a broad range of skin diseases. This study aimed to evaluate dermatologists’ confidence in teledermatology, its utility and limitations for dermatological conditions in primary care. Methods: An analytical study that used a survey for dermatologists who diagnosed 30,916 patients with 55,012 lesions through teledermatology during a 1-year project in S~ao Paulo, Brazil. Results: Dermatologists found teledermatology useful for triage and diagnosis, especially for xerotic eczema, pigmen- tary disorders and superficial infections. Their confidence in teledermatology was statistically higher by the end of the project (p ¼ 0.0012). Limitations included some technical issues and the impossibility to suggest how soon the patient should be assisted face-to-face by a dermatologist. The most treatable group of diseases by teledermatology was superficial infections (92%). The use of dermoscopy images would significantly increase the confidence to treat atypical naevi and malignant tumours (p < 0.0001 and p ¼ 0.0003 respectively). Follow-ups by teledermatology or feedback from primary-care physicians would be desirable, according to the dermatologists. Discussion: We found it interesting that dermatologists became increasingly confident in teledermatology after the project and how they classified teledermatology as useful for triage, diagnosis and even treatment of most types of skin conditions followed at primary care.
    [Show full text]
  • General Dermatology an Atlas of Diagnosis and Management 2007
    An Atlas of Diagnosis and Management GENERAL DERMATOLOGY John SC English, FRCP Department of Dermatology Queen's Medical Centre Nottingham University Hospitals NHS Trust Nottingham, UK CLINICAL PUBLISHING OXFORD Clinical Publishing An imprint of Atlas Medical Publishing Ltd Oxford Centre for Innovation Mill Street, Oxford OX2 0JX, UK tel: +44 1865 811116 fax: +44 1865 251550 email: [email protected] web: www.clinicalpublishing.co.uk Distributed in USA and Canada by: Clinical Publishing 30 Amberwood Parkway Ashland OH 44805 USA tel: 800-247-6553 (toll free within US and Canada) fax: 419-281-6883 email: [email protected] Distributed in UK and Rest of World by: Marston Book Services Ltd PO Box 269 Abingdon Oxon OX14 4YN UK tel: +44 1235 465500 fax: +44 1235 465555 email: [email protected] © Atlas Medical Publishing Ltd 2007 First published 2007 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Clinical Publishing or Atlas Medical Publishing Ltd. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. A catalogue record of this book is available from the British Library ISBN-13 978 1 904392 76 7 Electronic ISBN 978 1 84692 568 9 The publisher makes no representation, express or implied, that the dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations.
    [Show full text]
  • Proliferating Trichilemmal Cyst of the Scalp: Nine Cases and Literature Review
    Otorhinolaryngology-Head and Neck Surgery Research Article ISSN: 2398-4937 Proliferating trichilemmal cyst of the scalp: Nine cases and literature review ElBenaye J1,3*, Sinaa M2,3, Elkhachine Y1,3, Sakkah A1,3, Jakar A1 and Elhaouri M1 1Department of Dermatology, Moulay Ismail Military Hospital, Meknes, Morocco 2Department of Cytopathology, Moulay Ismail Military Hospital, Meknes, Morocco 3Department of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University (USMBA), Fes, Morocco Abstract Background: proliferating trichilemmal cyst (PTC) is a rare adnexal tumor, primarily sitting on the scalp of elderly women. Its evolution is generally benign despite the rare malignant cases described. We report a series of 9 cases of which one is malignant and metastatic. Material and methods: We retrospectively reviewed data of all patients with PTC seen at department of dermatology in the Meknes military hospital, between January 2013 and December 2017. Results: Nine cases of PTC were diagnosed, which 8 in elderly women, with 62 years mean age. Trauma was found in one third of cases correlated with rapid growth of the tumor. The latter was symptomatic in 2/3 of the cases. Ulceration involved only the malignant case. The size varied from 1,5 to 12 cm. Recurrence after surgery was noted in 2 cases (malignant tumor and multi-cystic tumor). Discussion: PTC appears to have a well-distinguished profile of the simple trichilemmal cyst. Some clinical and histological features may constitute prognostic factors of aggressiveness. Histological and immunohistochemical study is crucial in the management. A large excision remains the only guarantee of complete remission without recurrence or metastasis.
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
    Supplementary Online Content Tschandl P, Rosendahl C, Akay BN, et al. Expert-level diagnosis of nonpigmented skin cancer by combined convolutional neural networks. JAMA Dermatol. Published online November 28, 2018. doi:10.1001/jamadermatol.2018.4378 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set eAppendix. Neural Network Training eTable 1. Complete List of Diagnoses and Their Frequencies Within the Test-Set eTable 2. Education of Users According to Their Experience Group eTable 3. Percent of Correct Prediction of the Malignancy Status for Specific Diagnoses of a CNN Using Either Close-up or Dermatoscopic Images This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set A threshold cut at 0.2 (black) is found for a minimum of 51.3% specificity. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eAppendix. Neural Network Training We compared multiple architecture and training hyperparameter combinations in a grid-search fashion, and used only the single best performing network for dermoscopic and close-up images, based on validation accuracy, for further analyses. We trained four different CNN architectures (InceptionResNetV2, InceptionV3, Xception, ResNet50) and used model definitions and ImageNet pretrained weights as available in the Tensorflow (version 1.3.0)/ Keras (version 2.0.8) frameworks.
    [Show full text]
  • Histopathological Profile of Surgically Excised Scalp and Skull Lesions Asuman Kilitci¹ , Ziya Asan²
    DOI: 10.5152/cjms.2018.442 Original Article Histopathological Profile of Surgically Excised Scalp and Skull Lesions Asuman Kilitci¹ , Ziya Asan² 1Department of Pathology, Ahi Evran University School of Medicine, Kırşehir, Turkey ²Department of Neurosurgery, Ahi Evran University School of Medicine, Kırşehir, Turkey ORCID ID of the author: A.K. 0000-0002-5489-2222; Z.A. 0000-0001-8468-9156 Cite this article as: Kilitci A, Asan Z. Histopathological Profile of Surgically Excised Scalp and Skull Lesions. Cyprus J Med Sci 2018; 3: 63-7. BACKGROUND/AIMS Although subcutaneous lesions of the scalp are more common than those of the skull, few studies in literature have assessed the frequency of scalp and skull diseases. The goal of this study was to establish the frequency and main histopathological findings of these lesions. Our study is one of the largest series and shows that the incidence of surgically excised scalp masses includes an array of diseases. MATERIAL and METHODS We reviewed 265 extracranial masses from 173 patients. The mean age of the patients, gender distribution, localization and characteristics of lesions, histopathological type and radiological features were analyzed. RESULTS One-hundred (57.8%) patients were males and 73 (42.2%) were females. The mean age was 42.98 (range, 5-87). In total, 261 were within the scalp, 1 involved the scalp and skull and 3 were within the limits of the skull. Six lesions exhibited malignant features. There were 101 trichilemmal cysts; 74 epidermal cysts; 38 intradermal nevus; 8 verruca vulgaris;
    [Show full text]
  • NAIL CHANGES in RECENT and OLD LEPROSY PATIENTS José M
    NAIL CHANGES IN RECENT AND OLD LEPROSY PATIENTS José M. Ramos,1 Francisco Reyes,2 Isabel Belinchón3 1. Department of Internal Medicine, Hospital General Universitario de Alicante, Alicante, Spain; Associate Professor, Department of Medicine, Miguel Hernández University, Spain; Medical-coordinator, Gambo General Rural Hospital, Ethiopia 2. Medical Director, Gambo General Rural Hospital, Ethiopia 3. Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain; Associate Professor, Department of Medicine, Miguel Hernández University, Spain Disclosure: No potential conflict of interest. Received: 27.09.13 Accepted: 21.10.13 Citation: EMJ Dermatol. 2013;1:44-52. ABSTRACT Nails are elements of skin that can often be omitted from the dermatological assessment of leprosy. However, there are common nail conditions that require special management. This article considers nail presentations in leprosy patients. General and specific conditions will be discussed. It also considers the common nail conditions seen in leprosy patients and provides a guide to diagnosis and management. Keywords: Leprosy, nails, neuropathy, multibacillary leprosy, paucibacillary leprosy, acro-osteolysis, bone atrophy, type 2 lepra reaction, anonychia, clofazimine, dapsone. INTRODUCTION Leprosy can cause damage to the nails, generally indirectly. There are few reviews about the Leprosy is a chronic granulomatous infection affectation of the nails due to leprosy. Nails are caused by Mycobacterium leprae, known keratin-based elements of the skin structure that since ancient times and with great historical are often omitted from the dermatological connotations.1 This infection is not fatal but affects assessment of leprosy. However, there are the skin and peripheral nerves. The disease causes common nail conditions that require diagnosis cutaneous lesions, skin lesions, and neuropathy, and management.
    [Show full text]
  • Hair and Nail Disorders
    Hair and Nail Disorders E.J. Mayeaux, Jr., M.D., FAAFP Professor of Family Medicine Professor of Obstetrics/Gynecology Louisiana State University Health Sciences Center Shreveport, LA Hair Classification • Terminal (large) hairs – Found on the head and beard – Larger diameters and roots that extend into sub q fat LSUCourtesy Health of SciencesDr. E.J. Mayeaux, Center Jr., – M.D.USA Hair Classification • Vellus hairs are smaller in length and diameter and have less pigment • Intermediate hairs have mixed characteristics CourtesyLSU Health of E.J. Sciences Mayeaux, Jr.,Center M.D. – USA Life cycle of a hair • Hair grows at 0.35 mm/day • Cycle is typically as follows: – Anagen phase (active growth) - 3 years – Catagen (transitional) - 2-3 weeks – Telogen (preshedding or rest) about 3 Mon. • > 85% of hairs of the scalp are in Anagen – Lose 75 – 100 hairs a day • Each hair follicle’s cycle is usually asynchronous with others around it LSU Health Sciences Center – USA Alopecia Definition • Defined as partial or complete loss of hair from where it would normally grow • Can be total, diffuse, patchy, or localized Courtesy of E.J. Mayeaux, Jr., M.D. CourtesyLSU of Healththe Color Sciences Atlas of Family Center Medicine – USA Classification of Alopecia Scarring Nonscarring Neoplastic Medications Nevoid Congenital Injury such as burns Infectious Systemic illnesses Genetic (male pattern) (LE) Toxic (arsenic) Congenital Nutritional Traumatic Endocrine Immunologic PhysiologicLSU Health Sciences Center – USA General Evaluation of Hair Loss • Hx is
    [Show full text]
  • Histopathology Squamous Cell Carcinoma
    Squamous cell carcinoma - Mohs Ron Rapini MD No conflict of interest Josey Chair, Dept Dermatology • I am paid zero to speak at this Univ Texas Medical School at Houston MD Anderson Cancer Center course, other than travel • The tuition helps to run the ASMS programs Duplicate Actinic keratosis Actinic keratosis Rx • Whether you call it a “precancer” or • Treating orAKs is beyond this lecture “squamous cell carcinoma grade 1/2” or • Ill-defined dysplasias – usually a “field-effect” “SCC – AK type”, or “keratinocytic • Trying to eradicate totally is like playing intraepithelial neoplasia = KIN”, it still “whack a mole” so goal is to eradicate most doesn’t need Mohs surgery significant areas • Don’t over-read as invasive squamous cell ca • Cryo, curettage, laser, imiquimod, • AK and squamous cell carcinoma are often fluorouracil, diclofenac, etc multifocal with field effects in margins Keratinocytic intraepithelialDistribute Grading dysplasia in neoplasia = KIN 1, 2, 3 dysplastic nevi is analogous • Analogous to CIN, PIN, VIN 1,2,3 • Really in SKIN with most popular • NIH consensus conference 1992 system, we don’t have a “2”: recommended grading cytology despite Not lack of concordance AK = KIN-1 • I grade only cytology as mild, moderate, SCC in situ (Bowen’s) = KIN-3 Do severe 1 Lack of concordance on grading “dysplasia” in dysplastic nevi Other terms Piepkorn (J Cutan Pathol 6:542, 1992) • Bowenoid AK – “just call it found only 38% agreement SCCis?” Similar situation with KIN-2 (in between • Advanced AK – “beware” AK and SCC in situ) –
    [Show full text]
  • Pili Torti: a Feature of Numerous Congenital and Acquired Conditions
    Journal of Clinical Medicine Review Pili Torti: A Feature of Numerous Congenital and Acquired Conditions Aleksandra Hoffmann 1 , Anna Wa´skiel-Burnat 1,*, Jakub Z˙ ółkiewicz 1 , Leszek Blicharz 1, Adriana Rakowska 1, Mohamad Goldust 2 , Małgorzata Olszewska 1 and Lidia Rudnicka 1 1 Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008 Warsaw, Poland; [email protected] (A.H.); [email protected] (J.Z.);˙ [email protected] (L.B.); [email protected] (A.R.); [email protected] (M.O.); [email protected] (L.R.) 2 Department of Dermatology, University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany; [email protected] * Correspondence: [email protected]; Tel.: +48-22-5021-324; Fax: +48-22-824-2200 Abstract: Pili torti is a rare condition characterized by the presence of the hair shaft, which is flattened at irregular intervals and twisted 180◦ along its long axis. It is a form of hair shaft disorder with increased fragility. The condition is classified into inherited and acquired. Inherited forms may be either isolated or associated with numerous genetic diseases or syndromes (e.g., Menkes disease, Björnstad syndrome, Netherton syndrome, and Bazex-Dupré-Christol syndrome). Moreover, pili torti may be a feature of various ectodermal dysplasias (such as Rapp-Hodgkin syndrome and Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome). Acquired pili torti was described in numerous forms of alopecia (e.g., lichen planopilaris, discoid lupus erythematosus, dissecting Citation: Hoffmann, A.; cellulitis, folliculitis decalvans, alopecia areata) as well as neoplastic and systemic diseases (such Wa´skiel-Burnat,A.; Zółkiewicz,˙ J.; as cutaneous T-cell lymphoma, scalp metastasis of breast cancer, anorexia nervosa, malnutrition, Blicharz, L.; Rakowska, A.; Goldust, M.; Olszewska, M.; Rudnicka, L.
    [Show full text]
  • Cysts a Cyst Is a Benign, Round, Dome-Shaped Encapsulated Lesion
    Cysts A cyst is a benign, round, dome-shaped encapsulated lesion that contains fluid or semi-fluid material. It may be firm or fluctuant and often distends the overlying skin. There are several types of cyst. The most common are described here. Pseudocyst? Cysts that are not surrounded by a capsule are better known as pseudocysts. These commonly arise in acne. Cysts Epidermoid cysts are due to the proliferation of epidermal cells within the dermis. So basically the layers of skin that are supposed to be on the outside instead invaginate in. Skin is tucked in to form a sack that is lined by healthy epidermal cells that continue to multiply, mature and form keratin. These can be found just about anywhere on the body. A central pore or punctum may be present. Keratinous contents are soft, cheese-like and malodorous. The origin of a trichilemmal cyst is hair root sheath and, thus, these are often found on the scalp and are very firm. Inheritance is autosomal dominant. The origin of steatocystoma is the sebaceous duct within the hair follicle. A solitary steatocystoma is known as steatocystoma simplex. More often, there are multiple lesions (steatocystoma multiplex) on the chest, upper arms, axillae, neck and scrotum or vulva and this is usually an autosomal dominantly inherited disorder. The cysts arise in the late teens and 20s due to the effect of androgens and persist lifelong. They are freely moveable, smooth flesh to yellow color papules 3–30 mm in diameter. There is no central punctum. The content of the cysts is predominantly sebum.
    [Show full text]